938 related articles for article (PubMed ID: 12693150)
1. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
2. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
3. Hepatorenal syndrome.
Kramer L; Hörl WH
Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
[TBL] [Abstract][Full Text] [Related]
4. Hepatorenal syndrome.
Bataller R; Ginès P; Guevara M; Arroyo V
Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
[TBL] [Abstract][Full Text] [Related]
5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
6. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
7. Treatment of hepatorenal syndrome.
Kiser TH; Maclaren R; Fish DN
Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
[TBL] [Abstract][Full Text] [Related]
8. Hepatorenal syndrome: pathophysiology and management.
Wadei HM; Mai ML; Ahsan N; Gonwa TA
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1066-79. PubMed ID: 17699328
[No Abstract] [Full Text] [Related]
9. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Cárdenas A
Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
[TBL] [Abstract][Full Text] [Related]
10. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
11. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
12. [Hepatorenal syndrome in patients with liver cirrhosis].
Zaza S; Bonny O; Liaudet L
Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
[TBL] [Abstract][Full Text] [Related]
13. [Hepatorenal syndrome].
Lautrette A; Liotier J; Deteix P; Souweine B
Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
[TBL] [Abstract][Full Text] [Related]
14. The management of hepatorenal syndrome.
Carl DE; Sanyal A
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of hepatorenal syndrome].
Walter E
Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatorenal syndrome.
McCormick PA; Donnelly C
Pharmacol Ther; 2008 Jul; 119(1):1-6. PubMed ID: 18539334
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and treatment of hepatorenal syndrome.
Arroyo V; Fernandez J; Ginès P
Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
[TBL] [Abstract][Full Text] [Related]
18. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
19. Hepatorenal syndrome: a critical update.
Wadei HM
Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
